Viltepso®
Viltepso® is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: NS Pharma, Inc. |
CLASS: Antisense Oligonucleotide |
WHAT IT TREATS: |
PRESCRIBED BY: Neurologist
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Weekly |
Length of infusion: About 60 mins |
FOR MORE INFORMATION: |